Skip to main content
RNA logoLink to RNA
. 2023 May;29(5):570–583. doi: 10.1261/rna.079263.122

Design and off-target prediction for antisense oligomers targeting bacterial mRNAs with the MASON web server

Jakob Jung 1, Linda Popella 1, Phuong Thao Do 1,2, Patrick Pfau 3, Jörg Vogel 1,2, Lars Barquist 2,3,
PMCID: PMC10158992  PMID: 36750372

Abstract

Antisense oligomers (ASOs), such as peptide nucleic acids (PNAs), designed to inhibit the translation of essential bacterial genes, have emerged as attractive sequence- and species-specific programmable RNA antibiotics. Yet, potential drawbacks include unwanted side effects caused by their binding to transcripts other than the intended target. To facilitate the design of PNAs with minimal off-target effects, we developed MASON (make antisense oligomers now), a web server for the design of PNAs that target bacterial mRNAs. MASON generates PNA sequences complementary to the translational start site of a bacterial gene of interest and reports critical sequence attributes and potential off-target sites. We based MASON's off-target predictions on experiments in which we treated Salmonella enterica serovar Typhimurium with a series of 10-mer PNAs derived from a PNA targeting the essential gene acpP but carrying two serial mismatches. Growth inhibition and RNA-sequencing (RNA-seq) data revealed that PNAs with terminal mismatches are still able to target acpP, suggesting wider off-target effects than anticipated. Comparison of these results to an RNA-seq data set from uropathogenic Escherichia coli (UPEC) treated with eleven different PNAs confirmed that our findings are not unique to Salmonella. We believe that MASON's off-target assessment will improve the design of specific PNAs and other ASOs.

Keywords: peptide nucleic acid, antisense oligomers, antisense antibiotics, RNA sequencing, web server, off-targets

INTRODUCTION

Antimicrobial resistant (AMR) bacteria have become a major threat to human health, underscoring the urgency for the development of new types of antibiotics (Murray et al. 2022). Most clinically available antibiotics disrupt conserved cellular processes like transcription, translation, DNA replication, or cell wall maintenance (for review, see Baquero and Levin 2021). Therefore, antibiotic treatment often affects a wide spectrum of microbes and can disturb the natural balance of the human microbiome, potentially leading to dysbiosis (Vangay et al. 2015). To prevent this effect, ultranarrow spectrum antibiotics targeting specific pathogenic species or strains would be an important advance in antimicrobial research (Vogel 2020).

A promising approach is the use of antisense oligomers (ASOs) that inhibit the translation of essential genes by binding to the translation initiation region (TIR), making them highly specific. Popular ASOs include peptide nucleic acids (PNAs), which are synthetic nucleic acid analogs commonly designed to bind the ribosome binding site (RBS) or start codon of a gene of interest (Nielsen et al. 1991; Egholm et al. 1993; Dryselius et al. 2003; Nielsen 2006). Their neutral pseudopeptide backbone protects PNAs from degradation by nucleases and proteases while conferring higher binding affinities compared to DNA or RNA. To facilitate cellular uptake by bacteria, PNAs are coupled to short (<30 aa), often positively charged cell penetrating peptides (CPPs) (Eriksson et al. 2002). PNAs have been successfully applied to inhibit growth of a wide variety of microorganisms both in culture and in animal models (Tan et al. 2005; Oh et al. 2014; Sully and Geller 2016; Hegarty and Stewart 2018; Barkowsky et al. 2019; Lee et al. 2019; Pifer and Greenberg 2020). The ability of PNAs to selectively silence any gene of interest can also have other applications, such as to potentiate conventional antibiotics by silencing nonessential genes involved in drug resistance or tolerance (Courtney and Chatterjee 2015; Aunins et al. 2020).

Despite nearly two decades of research, design rules for PNA sequences are based on only a handful of studies. Early work in E. coli investigating PNAs of varying lengths suggested that a length of nine to 12 bases is optimal to reliably inhibit target gene translation (Good et al. 2001). More recently, PNA length was shown to be a major constraint for cell entry, and 10 bases was proposed as an ideal length (Goltermann et al. 2019). Regarding sequence composition, PNAs rich in purines show reduced solubility (Nielsen et al. 1996; Good 2002), while a low GC content can result in low binding affinities between PNAs and its target (Giesen et al. 1998). Further, self-complementarity of PNA sequences needs to be avoided to prevent self-interaction (Good 2002).

Another important consideration for PNA design is target site uniqueness. Because of the short length of PNAs, full or partial complementarity to genomic regions other than target region is frequent. In addition, the TIR, spanning the Shine–Dalgarno sequence (SD) and/or start codon, is often not completely unique. We refer to these unintended complementary regions as off-target matches. Naturally, off-target matches with one or two base pair (bp) mismatches are very common for 10-mer PNAs in bacteria. It is thus important to determine whether mismatches interfere with PNA targeting. Cell-free hybridization experiments have established that single mismatches in PNA–DNA and PNA–RNA duplexes substantially decrease binding affinity (Jensen et al. 1997; Ratilainen et al. 2000). In addition, PNAs with single and double mismatches to bacterial target mRNAs have strongly reduced effects on target gene expression and growth inhibition compared to fully complementary PNAs (Good and Nielsen 1998; Good et al. 2001; Hatamoto et al. 2009). A more recent study, in which single mismatches were introduced in PNAs of different lengths targeting the acpP gene in E. coli, showed a negative correlation between PNA melting temperatures and minimum inhibitory concentrations (Goltermann et al. 2019). However, these results were based on a small number of tested PNAs, making it difficult to draw general conclusions. Nevertheless, PNAs are thought to tolerate very few mismatches, making them highly specific nucleic acid–binding compounds.

In bacterial PNA design, little attention has therefore been given to off-targets that harbor one or two bp mismatches. Yet, broad consideration of all possible off-target effects is essential for several reasons. First, PNAs that bind to TIRs of other genes can cause unwanted cellular responses. This may be particularly problematic when targeting nonessential genes with the goal of selectively silencing gene expression rather than killing the bacteria. Second, binding to a large number of off-target sites may reduce PNA availability by sequestering free PNAs, a phenomenon known from bacterial small RNA sponges (Ziebuhr and Vogel 2015). While it has been generally recommended to avoid off-target matches during PNA design (Good 2002; Dryselius et al. 2003), the degree of complementarity required to mediate off-target effects as well as the overall transcriptomic response caused by off-targets have not been investigated in detail yet.

Although there are some guidelines for the design of effective PNA sequences (Dryselius et al. 2003), researchers usually rely on manual design to find the best sequence to target a selected gene. This is because the existing computational tools either lack a user-friendly interface or are designed for ASOs targeting mammalian cells. PNA Finder, for example, can be used to design PNA sequences and screens for sequence-specific attributes and off-target effects (Eller et al. 2021). However, because it requires installation of dependencies in a Bash shell, it may be difficult to use for those with limited computational experience. Other methods, such as PNA Tool (https://www.pnabio.com/support/PNA_Tool.htm), are easy to use, but only screen for sequence-specific attributes, without considering off-target effects in bacteria.

Here, to facilitate the design of bacterial ASOs we developed MASON (make antisense oligomers now), a user-friendly web server which helps researchers in designing PNAs for any annotated bacterial gene while predicting melting temperature (Tm) and possible off-targets in the bacterium of interest. To improve the off-target prediction algorithm of MASON and to investigate the effect of mismatches on PNA efficiency, we designed a series of 10-mer PNAs with serial double mismatches based on a PNA targeting the acpP mRNA of Salmonella enterica serovar Typhimurium strain SL1344 (henceforth Salmonella). We found that double mismatches at the termini of PNAs do not fully abrogate the growth inhibitory and transcript-depleting effects of a PNA. Accordingly, PNAs with partial complementarity in proximity to the translational start region of off-target mRNAs can substantially reduce transcript levels in both Salmonella and uropathogenic Escherichia coli (UPEC). We incorporated these findings into MASON to improve its off-target predictions. MASON is freely available as both a web server and command line tool.

RESULTS

MASON—a web server for efficient ASO design

To facilitate the design of bacterial ASOs, we developed a user-friendly web application called MASON (https://www.helmholtz-hiri.de/en/datasets/mason; Supplemental Fig. S1). Users can specify the organism of interest, a target gene, the ASO length and the number of allowed mismatches for off-targets (Fig. 1A; Supplemental Fig. S2). A predefined set of four annotated bacterial strains, specifically E. coli str. K12 substr. MG1655, Salmonella enterica subsp. enterica serovar Typhimurium SL1344, Clostridium difficile 630, and Fusobacterium nucleatum ATCC 23726, can be selected from a dropdown menu (Supplemental Fig. S2). Furthermore, custom bacterial genomes can be added manually with a reference fasta file and an annotation file in gff format, which can be downloaded for a wide variety of bacteria from NCBI. Finally, there is an additional option to screen for off-targets in human genes and genes of the human microbiome.

FIGURE 1.

FIGURE 1.

The MASON web server designs ASO sequences and predicts off-targets. (A) Users specify an organism of interest, the target gene, ASO length and allowed number of mismatches for off-targets. MASON then generates ASO sequences and their attributes in between 10 and 120 sec. (B) The generated ASO sequences are designed to bind the start codon (marked in dark blue) of the target mRNA. (C) MASON predicts critical off-target binding regions for each ASO. An off-target is termed “critical” if the respective ASO sequence binds more than seven consecutive bases of the off-target mRNA. Off-targets are predicted both for the whole transcriptome (steel blue) and for translation initiation regions (TIR, light blue) of other genes. TIR off-targets are defined as having the start of the binding region between −20 to +5 bases relative to the start codon.

Once the user submits the input, MASON finishes its calculation in between 10 sec and 2 min, depending on the size of the target genome, choice of ASO length, and allowed number of mismatches for off-targets (Fig. 1A). For each selected target gene, MASON outputs all candidate ASO sequences that overlap the start codon (in a window ranging from −7 to +10 for 10-mers, default) (Supplemental Fig. S3A). Because it is often desirable to target the RBS in the 5′ UTR of a transcript, the user can opt to specify the number of bases upstream of the start codon for which additional ASOs are designed.

Recent reports using different E. coli strains showed that PNA–mRNA Tm positively correlates with growth inhibition (Goltermann et al. 2019) and is associated with in vitro translation inhibition of the target gene (Popella et al. 2022). We therefore integrated Tm predictions for PNA–RNA duplexes as a feature in MASON (see Materials and Methods, Supplemental Fig. S3B). To predict the Tm, we applied a nearest-neighbor method for RNA–RNA duplexes (Xia et al. 1998), which is incorporated in the MELTING 5 platform (Dumousseau et al. 2012). Next, to test whether our predictions perform well, we compared them to experimental Tm measurements of PNA–RNA duplexes (Goltermann et al. 2019) and to a PNA–DNA prediction algorithm (Giesen et al. 1998) used by the PNA Tool and the PNA Finder toolbox (Supplemental Fig. S4; Eller et al. 2021). Our predictions correlate well with the experimentally measured Tm, but the absolute Tm was consistently underestimated by around 10°C. This is likely due to increased stability of PNA–RNA duplexes compared to RNA–RNA interactions (Egholm et al. 1993). Interestingly, our predictions based on an RNA hybridization model were closer to experimental PNA–RNA stability measurements than those predicted by the PNA–DNA interaction prediction algorithm (Supplemental Fig. S4).

Due to the short length of ASOs, the frequency of off-target sites with zero or few mismatches can be high. We therefore established an off-target prediction algorithm in MASON. The algorithm screens for all possible off-target matches with a user-adjusted number of mismatches in the target organism's annotated coding sequence (CDS) and 30 bases upstream (5′) of the respective CDS (see Materials and Methods for details). We divide off-targets into two categories: (i) off-target sites in the whole transcriptome based on annotated CDSs; and (ii) off-target sites in the TIR of nontarget genes with start positions 20 bases upstream of the annotated start codon until five bases downstream (Fig. 1C; Supplemental Fig. S3C). The results page of MASON additionally provides a table that summarizes sequence properties, the number of self-complementary bases and off-target sites (Supplemental Fig. S5).

We also created a command line version of MASON, with added features that facilitate high-throughput design of ASOs. The command line version allows users to skip the design step and use previously designed sequences as direct input, thereby permitting parallel screening of a large number of ASO sequences in a short time. It also adds the possibility to screen multiple bacterial species for off-targets, which can be useful for applying ASOs to cocultures or microbial communities. As we want to keep the web interface fast and efficient, these functions are only available in the command line version of MASON, which runs on Linux-based PCs, servers or high-performance clusters.

PNAs targeting acpP retain growth-inhibitory activity despite terminal double mismatches

The algorithm of MASON considers off-target matches only if at least seven consecutive matching bases exist. To investigate whether this definition of “critical” off-targets is reasonable, we took a scanning approach to design a series of 10-mer PNAs based on an acpP-targeting PNA. AcpP is an essential protein and its mRNA has been successfully targeted with PNAs and phosphorodiamidate morpholino oligomers (PMOs) before (Dryselius et al. 2003; Tilley et al. 2006; Moustafa et al. 2021; Popella et al. 2021). We introduced two adjacent mismatch positions from the amino to the carboxyl terminus of the acpP-targeting PNA, while preserving the initial GC content of 40% (Fig. 2A; Supplemental Table S1). We refer to this series of mismatched PNAs by the position of the first mismatch, for example, mm1 refers to the PNA with mismatches at positions one and two. Additionally, we used a scrambled PNA to profile unspecific effects (Supplemental Table S1). All PNAs were fused to a KFFKFFKFFK peptide (KFF), a potent CPP for Salmonella (Popella et al. 2021).

FIGURE 2.

FIGURE 2.

PNAs with two terminal mismatches show position-dependent effects on Salmonella growth and mRNA levels. (A) Workflow of experiments. acpP PNA (acpP) and nine acpP-related PNAs with two serial mismatches (mm1–mm9) were designed and tested against S. enterica serovar Typhimurium strain SL1344. PNA sequences are shown from their carboxyl- to amino terminus (from left to right). A 10-mer region of the acpP mRNA (blue) including its “AUG” start codon (bold) was targeted by one fully complementary PNA and nine mismatched PNAs, all coupled to the CPP KFF (green). Mismatches in the PNA sequences are marked in red. (Upper right) Minimum inhibitory concentration experiments were performed by challenging Salmonella with different CPP–PNA concentrations for 24 h while measuring cellular growth. (Lower right) RNA sequencing was performed to profile RNA levels after short-term CPP–PNA exposure. (B) Summary of growth experiments with Salmonella treated with KFF–PNAs. (Top) Heatmap of MIC values, determined as the lowest concentration that fully inhibits growth after 24 h (see Supplemental Fig. S6). (Bottom) Heatmap of OD600 after 24 h treatment with 10 µM of the indicated PNA, or a water control. (C) Transcript levels of acpP and fabF after short-term exposure (15 min) to 5 µM of the indicated PNA relative to the untreated control condition. The barplot shows the negative log2 fold change of acpP (steel blue) and fabF (light blue) transcripts from the RNA-seq experiment. Asterisks indicate significant down-regulation (log2FC < −1 and FDR < 0.001).

First, we determined the minimum inhibitory concentration (MIC) of each PNA, defined as the lowest concentration that fully inhibits visible growth (OD600 nm <0.1) of Salmonella (∼105 cfu/mL). Consistent with previous results (Popella et al. 2021), the PNA targeting the TIR of the acpP transcript with zero mismatches had an MIC of 1.25 µM. Two bp mismatches led to greater than fourfold increases in MIC values compared to the fully matched acpP PNA, most likely due to reduced binding affinity (Fig. 2B). Interestingly, we observed a mismatch-position dependent growth inhibition of Salmonella (Fig. 2B; Supplemental Fig. S6). PNAs that carry mismatches at either end of the sequence (i.e., mm1 and mm9) have MICs of 5 µM, whereas more central mismatch positions lead to MICs of 10 µM or higher (Fig. 2B). This is also seen in Salmonella growth curves (Supplemental Fig. S6), where growth defects become apparent at lower concentrations for mm1 and mm9 compared to PNAs with mismatches at more central positions. PNAs mm3 and mm4, which possess two mismatches to the start codon AUG, did not show any growth effect even at high concentrations, whereas mm1, mm8, and mm9 were still able to interfere with Salmonella growth (Supplemental Fig. S6).

PNAs with terminal double mismatches retain ability to trigger target mRNA depletion

Previously, we have shown that RNA-seq can serve as readout for direct effects on transcript levels after short-term treatment with a PNA targeting acpP in Salmonella (Popella et al. 2021). To analyze to what degree the designed series of PNAs affect on- and off-target mRNA levels compared to the “on-target” acpP PNA, we performed RNA-seq on Salmonella after a 15-min exposure to 5 µM of the KFF-conjugated PNAs. To identify differentially expressed genes, we contrasted transcript levels in PNA-treated Salmonella with that of untreated control samples. First, we examined depletion of the target transcript, acpP, and fabF, a gene cotranscribed with acpP and shown to be concomitantly depleted by acpP PNA (Fig. 2C; Popella et al. 2021). In contrast to the scrambled control, mRNAs of both acpP and fabF were significantly depleted by the fully matching acpP PNA (log2FC < −1 and FDR < 0.001). mRNA depletion caused by mismatched PNAs correlated with the MIC values (Fig. 2B,C). In particular, PNAs mm1 and mm9, which both had an MIC of 5 µM, resulted in significant (log2FC < −1 and FDR < 0.001) mRNA depletion of both acpP [log2FC = −1.6 (mm1) and −2.1 (mm9), FDR < 0.001] and fabF (log2FC = −1.2 (mm1) and −1.9 (mm9), respectively, FDR < 0.001) (Fig. 2C). mm8 also induced significant depletion of both transcripts, indicating that only seven consecutively matching bases can be sufficient to affect target transcript levels. On the other hand, PNA sequences with central mismatches (mm3 through mm7) did not cause a significant depletion of the target mRNAs, consistent with their negligible effect on Salmonella growth (Fig. 2B,C). Altogether, these data show that PNAs with double mismatches in their termini and seven or more consecutive nucleobases available for base-pairing retain antisense activity based on growth inhibition and depletion of acpP transcript levels.

PNAs affect mRNA levels of off-target genes in a mismatch-dependent manner in both Salmonella and UPEC

Next, we analyzed the effects of our series of PNA variants on the complete Salmonella transcriptome. Principal component analysis (PCA) showed a clear separation on the first principal component between untreated control samples and the KFF–PNA conjugates, suggesting that the dominant effect in our data set was caused by KFF–PNA treatment itself, and not specifically due to depletion of acpP (Supplemental Fig. S7B). The global transcriptomic response to PNAs differs across PNA treatments and depends on the chosen PNA sequence (Fig. 3). Interestingly, more genes are up-regulated than depleted in all samples (Fig. 3; Supplemental Fig. S8A). As shown previously in both Salmonella and UPEC, the most strongly up-regulated genes after short-term KFF–PNA exposure are part of an envelope stress response (Supplemental Fig. S9; Popella et al. 2021, 2022). In line with this observation, gene set analysis revealed that genes of the PhoPQ and PmrAB regulons as well as the KEGG pathways “Two component system” and “cationic antimicrobial peptide (CAMP) response” are strongly induced upon PNA exposure for all PNA conjugates (Supplemental Fig. S9).

FIGURE 3.

FIGURE 3.

Transcriptomic profiles of Salmonella in response to 15 min of treatment by PNAs. Volcano plots show changes in Salmonella transcript levels as fold change (log2) compared to the untreated (water) control sample on the x-axis. The y-axis shows false discovery rate (FDR)-adjusted P-values (−log10, y-axis). A scrambled control PNA (A), the fully matching acpP PNA (B), and all double-mismatch PNA samples (CK) are shown. Significantly differentially expressed (DE) genes are characterized by an absolute fold change >2 (depleted if log2FC < −1, up-regulated if log2FC > 1; vertical dashed line) and an FDR-adjusted P-value <0.001 (−log10FDR > 3, horizontal dashed line). Target genes (acpP and fabF) are labeled and highlighted in orange. Genes with zero-, one-, and two-mismatch complementarity at the translation initiation region with the respective PNA are highlighted in cyan, blue, and dark blue, respectively.

Contrary to the consistent pattern of up-regulated genes, genes with significantly reduced mRNA levels differ between the PNA samples. This suggests that mRNA depletion might be PNA-sequence dependent (Fig. 4A). To determine whether the down-regulation of transcripts is caused by off-target effects, we ran MASON to search for off-target sites for all PNAs in TIRs of genes and manually checked whether significantly depleted genes have complementarity with the respective PNA sequence. Interestingly, many significantly down-regulated genes have complementarity to the PNA with up to three mismatches in their TIR (Figs. 3, 4A). In total, of 160 significantly depleted genes across all samples, we identified off-target sites for 68 (Supplemental Fig. S8B).

FIGURE 4.

FIGURE 4.

Changes in Salmonella (A) and UPEC (B) gene expression in response to PNA treatment, inferred from RNA-seq data. The heatmap shows genes which rank among the top five significantly enriched and depleted genes of each sample. Columns are ordered by decreasing log2FC in the sample treated with the fully matching acpP PNA. Colors indicate the log2 fold change of the respective gene after 15 min of PNA exposure, with orange and blue showing positive and negative differences in gene expression, respectively. Asterisks indicate significant changes (absolute log2FC > 1, FDR < 0.001). Each row represents one PNA condition and each column a specific gene. The top five regulated genes (based on P-value) with an absolute fold change >2 and FDR < 0.001 (marked with asterisks) are shown for each sample. Heatmap rectangles are framed if the PNA-gene pair has a predicted off-target with 0, 1, 2, or 3 mismatches. The frame thickness denotes the complementarity of the gene-PNA pair; the less mismatches the thicker the frame.

Based on acpP PNA-dependent depletion of fabF, the gene downstream from acpP, we also assigned off-target status to genes lying immediately downstream (<30 base gap) of an off-target gene. For these, we observed a similar coregulation, for example, the mm1 PNA has complementarity with the nuoA TIR with 1 bp mismatch at position 10, and depletes the 12 genes downstream from the nuo operon as well as nuoA itself (Supplemental Fig. S10). These polar effects are likely caused by the transcription of multiple genes from a single promoter within bacterial operons.

To test whether these results are specific to Salmonella, we applied the same bioinformatics analysis to a published transcriptomic data set in which UPEC were treated with 11 different PNAs targeting various essential genes (Popella et al. 2022). The overall transcriptomic pattern closely resembles the data in the present study (Fig. 4A,B; Supplemental Fig. S8A,C). Specifically, we identified a number of consistently up-regulated genes, many from outer membrane sensors and two component systems. This is likely due to the envelope stress response triggered by CPP-coupled PNAs (Fig. 4A,B; Supplemental Fig. S9; Popella et al. 2021, 2022). Of the 369 unique significantly depleted genes, we observed off-target sites in TIRs of 176 genes (Fig. 4B; Supplemental Fig. S8D). For example, the PNA targeting ftsZ had full complementarity to the TIR of ybaB, one of the significantly depleted genes. These comparisons suggest that, in both organisms, PNA complementarity to TIRs of nontarget genes often leads to depletion of the respective mRNAs.

Mismatch position influences the degree of off-target mRNA depletion

So far, we found that PNA complementarity with TIRs of off-target genes with few mismatches can induce mRNA depletion. We next wanted to test whether this effect depends on the specific position of the mismatches within the PNA sequence, as we saw with the PNA variants targeting acpP in Salmonella.

For predicted off-targets with 1–3 bp mismatches in Salmonella and UPEC, we determined the most central mismatch position. For instance, if there was an off-target binding site with mismatches at positions one and three, we counted the mismatch at position three. We then plotted the most central mismatch position against the percentage of off-targets that are significantly depleted in the RNA-seq data sets (Fig. 5A,D). In these plots, a value of one includes off-target genes with mismatches at positions one and/or 10, whereas a value of five includes all off-targets with their most central mismatch at positions four and/or five. Our results show that of all off-targets with mismatches at a terminal position 50% and 57% of genes are significantly depleted in Salmonella and UPEC, respectively. The fraction of significantly depleted genes decreases rapidly as the mismatch position moves closer to the center (Fig. 5A,D). These results suggest that a longer stretch of matching bases is more likely to trigger off-target mRNA depletion, while central mismatches reduce the likelihood of an off-target effect.

FIGURE 5.

FIGURE 5.

Mismatch position within the PNA target region dictates the degree of the off-target effect. The TIR of all genes were screened for complementarity to the PNA with a maximum of three mismatching bases. Genes with less than five counts per million were excluded from the analysis. For all off-targets with >0 mismatches, the most central mismatch was determined and plotted against the percentage of significantly down-regulated genes for the Salmonella (A) and UPEC (D) data sets. Off-targets with a maximum base-pairing stretch (i.e., consecutive matches without mismatch) of ≥7 were compared to the rest of the off-targets in Salmonella (B) and UPEC (E). Hypergeometric P-values on top of the bars test for enrichment of differentially depleted genes in the RNA-seq data sets relative to random draws with the same sample size. Log2 fold changes of off-target genes with <7 and ≥7 were additionally plotted using violin plots for genes with log2FC less than 0 in Salmonella (C) and UPEC (F). The violin plots show the kernel probability density of log2FCs and an additional boxplot denoting median, interquartile range, and potential outliers of the data.

To define a general rule for PNA design, we assessed whether the longest stretch of matching bases can be used as a predictor of off-target effects. We observed that for Salmonella and UPEC, 15.8% and 17.7% of all off-targets with at least seven consecutive matches were significantly depleted, respectively (Fig. 5B,E). This is likely an underestimate of the total number of effective off-targets, as we have recently shown that targeting of mRNAs by PNAs does not necessarily lead to depletion of the transcript (Popella et al. 2022). Low PNA–mRNA affinity appears to ameliorate off-target activity, as we found that requiring a predicted Tm of >20°C increased the fraction of depleted off-targets to 23.7% and 25.9%, respectively (Supplemental Fig. S11). On the other hand, <5% of genes were depleted if they had an off-target site of six or less consecutive matches. Using a hypergeometric test, we confirmed that the observed effects in the samples with at least seven consecutive matches cannot be explained by random draws (P < 10−23 and P < 10−28 for Salmonella and UPEC, respectively), whereas the <5% of depleted genes with off-target sites of six or less consecutive matches are consistent with a random draw (P > 0.5) (Fig. 5B,E). We also observed a stronger overall depletion for transcripts with off-targets of at least seven consecutive matches (Fig. 5C,F). We therefore defined off-targets as “critical” only when they have at least seven consecutive matching bases and incorporated this finding into MASON (Fig. 1C). These data highlight that determining the number of consecutively matching bases can improve off-target prediction of PNAs in bacteria.

DISCUSSION

Here, we present MASON, a web tool that facilitates the design of PNA sequences targeting bacterial genes. We also provide experimental evidence to justify MASON's off-target prediction, which considers the mismatch position within the PNA. Combining growth measurements and RNA-seq analyses, we show that 10-mer PNAs targeting the essential gene acpP with terminal double mismatches retain their ability to inhibit Salmonella growth and to reduce transcript levels. Bioinformatic analysis of transcriptomic data sets reveals the effects of PNAs on transcripts with off-target binding sites and shows how the position of mismatches impacts these effects. Specifically, our analyses demonstrate that off-target binding sites can trigger mRNA depletion when at least seven consecutive bases match the PNA sequence. Our data argue for the importance of allowing terminal mismatches for off-target assessment of PNAs, especially when long stretches of the PNA can bind the mRNA.

There are various computational tools that aid the design of antisense oligonucleotides, RNAi, and CRISPR gRNAs that target eukaryotic genes (Chalk and Sonnhammer 2002; Owczarzy et al. 2008; Liu et al. 2020; Li et al. 2021; Sciabola et al. 2021). However, these methods are not suitable for designing short bacterial PNAs because these usually apply different design rules due to differences in binding affinity, mismatch tolerance, sequence length, and mode of delivery. Tools for designing bacterial PNAs are rare. First, PNA Finder is a toolbox that generates PNA sequences for a set of genes while considering issues like self-complementarity, solubility and off-target sites (Eller et al. 2021). A drawback of this method is that it only runs on a Bash shell, making it difficult to install for researchers without computational expertise. Second, PNA Tool is a freely accessible web server which screens specified PNA sequences, predicts PNA–DNA Tm and analyzes other PNA-specific attributes like GC content and self-complementarity (https://www.pnabio.com/support/PNA_Tool.htm). However, it does not help in the design of sequences for a specific gene nor does it evaluate organism-specific target and off-target effects. In contrast, MASON is an easy-to-run web server that designs bacterial PNA sequences for selected bacterial genes and predicts off-target effects as well as Tm and other attributes.

While we designed MASON for PNA sequences, it is likely similarly useful for the design of other ASOs, such as phosphorodiamidate morpholino oligomers (PMOs). PMOs are also nucleic acid mimics that only differ in their backbone compared to PNAs (Iversen 2001). Since PMOs take advantage of a similar mechanism for target gene inhibition (Geller et al. 2003; Deere et al. 2005), they could show similar off-target effects as well.

We showed that 10-mer PNAs with consecutive double mismatches are still able to inhibit the expression of acpP, if these mismatches are located at the termini of the PNA. We recently also observed this mismatch-position dependent off-target effect by cell-free in vitro ribosome profiling (Hör et al. 2022), adding further confidence to this observation. The fact that PNAs with as few as seven consecutive matches can retain activity suggests that the design of PNAs shorter than 10 nucleobases is feasible. Because PNA length is an important bottleneck that limits cellular entry (Goltermann et al. 2019), shorter PNAs might improve cellular uptake. While previous studies observed reduced PNA activity at a length of less than 10 bases (Good et al. 2001; Goltermann et al. 2019), we recently found that 9-mer PNAs targeting essential genes in UPEC were as efficient as their 10-mer counterparts in inhibiting bacterial growth in some cases (Popella et al. 2022).

The MASON web server currently designs PNAs targeting mRNA sequences overlapping the TIR of a target gene, as this region has been previously shown to be most effective for PNA-based inhibition of translation. In a pioneering study in E. coli, Dryselius et al. (2003) designed PNAs targeting all positions in the mRNA of the acpP and lacZ genes, finding that only the regions around the SD sequence and the start codon are potent targets for inhibiting protein production (lacZ) or preventing cellular growth (acpP). This position-dependent effect of PNAs led us to focus on off-targets in the TIR sequence, which could be particularly problematic when PNAs are used for gene silencing rather than killing target bacteria.

We will continue to apply data-driven methods to improve future versions of MASON in our effort to provide general design principles for bacterial ASOs, and we hope that MASON will become a widely used and evolving resource for the design of antisense drugs targeting bacterial pathogens.

MATERIALS AND METHODS

MASON web browser

MASON (make antisense oligomers now) is a web server that provides researchers with ASO designs targeting bacterial genes of interest (Supplemental Fig. S1). There are five required user inputs (Supplemental Fig. S2): (i) a custom ID for later retrieval of the result; (ii) the genome and annotation of a bacterium of interest in fasta and gff format, or alternatively, selection of one of four preloaded bacteria comprising Escherichia coli str. K12 substr. MG1655, Salmonella enterica subsp. enterica serovar Typhimurium SL1344, Clostridium difficile 630, and Fusobacterium nucleatum ATCC 23726; (iii) the locus tag of one or more target genes, or for preloaded organisms, a selection from a dropdown menu of experimentally determined essential genes; (iv) the length of the designed ASOs; and (v) the allowed number of mismatches for off-target screening. In default settings, only ASOs overlapping the start codon are designed. Optionally, additional 5′ UTR sequences upstream of the start codon can be selected to target the RBS, and genes from the human genome or the microbiome can be additionally screened for off-targets.

MASON then runs for 10–120 sec per target gene before returning the output. The output consists of three main elements (Supplemental Fig. S3). First, a heatmap visualizing all designed ASO sequences is shown, where the target mRNA and alignment of each ASO is visualized along with the respective start codon (Fig. 1B; Supplemental Fig. S3A). All possible ASOs spanning the target region are designed, with the exception of ASOs with more than 60% self-complementarity. Self-complementarity was defined as the maximal number of consecutive Watson and Crick matches of the ASO with itself, aligned in either direction. Second, for each ASO sequence, Tm between mRNAs and ASOs are visualized in a barplot (Supplemental Fig. S3B). Third, the number of predicted off-target sites for each ASO are visualized in a barplot, summarizing off-targets in both the whole transcriptome, as well as in the TIR of other genes in the selected organisms (Fig. 1C; Supplemental Fig. S3C). Finally, an additional summary table reports all aforementioned attributes along with general features such as position from start site and self-complementarity (Supplemental Fig. S5). The web interface was written using the python-based web-framework Flask (Grinberg 2018). The MASON website can be freely accessed at https://www.helmholtz-hiri.de/en/datasets/mason. The code can be viewed and accessed freely at https://github.com/BarquistLab/mason.

MASON algorithm

The code was written in Python (v3.7), R (v4.1.1) with various modules from the Biopython and Bioconductor environments (Cock et al. 2009; Huber et al. 2015). Briefly, MASON takes the target gene and designs all possible ASO sequences which are complementary to the region overlapping the start codon of the target gene and the specified upstream region. Next, the number of self-complementary consecutive bases are calculated with the SequenceMatcher package from the difflib python package. If the length of self-complementarity accounts for more than 50% of the ASO length, the respective sequence is dropped and not used for further analysis. Tm of the ASO-target mRNA duplex are calculated using the R package rmelting (v1.8.0) of the MELTING 5 platform (Dumousseau et al. 2012). Specifically, the melting function is applied for calculating the Tm of RNA–RNA duplexes using a nearest-neighbor algorithm (Xia et al. 1998).

For identifying off-target sites in the transcriptome, the supplied genome files are screened for motifs similar to the target region of the respective ASO. Specifically, the SeqMap tool was used to map the targeted mRNA sequence to mRNA sequences, with the specified option for allowed mismatches (Jiang and Wong 2008). The allowed mismatches are chosen in the user input in the start form of the web server and are added to the Seqmap command (Supplemental Fig. S2). Two to three mismatches were used here and were shown to be a good option to capture off-targets for 10-mer PNAs. Only “critical” off-targets with at least seven consecutive matching bases are kept for the analysis. For screening total off-targets, the whole transcript sequence of each annotated gene is used. Off-target sites in the TIR of transcripts are defined as binding regions with the first base in the region between −20 and +5 bases relative to the annotated start site of the CDS.

The off-target screen for the human microbiome was created with data from the HMP (Human Microbiome Project Consortium 2012). The genome and annotation files of all available complete genomes (2179) were downloaded from the NCBI BioProject collection. Next, start regions of all annotated transcripts (in total, 5,515,510 regions) were extracted and used for the additional off-target screen, using custom Linux bash commands. The human genome (GRCh38) was downloaded from the NCBI and full transcript sequences were extracted using the getfasta command of the BEDTools suite (Quinlan and Hall 2010). Finally, the results are visualized as described in the previous section.

MASON command line tool

The command line version of MASON can be accessed and downloaded from https://github.com/BarquistLab/mason_commandline. It can be run from any Linux environment after installing all dependencies. The tool uses the same algorithms/code as the web tool with two additions: (i) the user has the option to specify an ASO sequence without any input gene. This option prevents MASON from designing new ASO sequences and instead uses the input ASO sequences for off-target analysis; (ii) there is an option to specify additional nontarget organisms which are screened for off-targets.

Bacterial strains and peptide nucleic acids (PNAs)

Salmonella enterica serovar Typhimurium strain SL1344 (provided by D. Bumann, MPIIB Berlin, Germany [Hoiseth and Stocker 1981]; internal strain number JVS-1574) was used throughout this study. S. enterica SL1344 was cultured in noncation adjusted Mueller-Hinton Broth (MHB, BD Difco, Thermo Fisher Scientific) with aeration at 37°C and 220 rpm shaking. PNAs conjugated to the peptide KFFKFFKFFK (KFF) were obtained from Peps4LS GmbH. Quality and purity control of these constructs was performed by mass spectrometry and HPLC (purity >98%). PNAs (Supplemental Table S1) were dissolved in nuclease-free ultrapure water and heated at 55°C for 5 min prior to use. By measuring the absorbance at 260 nm using a NanoDrop spectrophotometer (A260 nm; Thermo Fisher), the concentrations of PNA solutions were calculated based on their extinction coefficient. Low retention pipette tips and low binding Eppendorf tubes (Sarstedt) were used for all PNA solutions. PNAs were stored at −20°C.

PNA selection and design

A 10-mer PNA targeting the start codon (−5 to +5 relative to CDS start) of the acpP gene served as a positive control. Nine additional PNAs were designed, containing the same sequence but with double mismatches starting in each possible location from one to nine (Fig. 2A; Supplemental Table S1). The mismatch PNAs were designed so that the GC content was the same as the control sequence, at 40%. That is, for each mismatch, guanines were swapped to cytosines and adenines to thymines, and vice versa (Fig. 2A; Supplemental Table S1). The number of off-targets were analyzed using the MASON command line tool.

Minimum inhibitory concentration (MIC) determination

For MIC determination, the broth microdilution method was applied according to the Clinical and Laboratory Standards Institute guidelines and slightly modified from a recently published protocol (Goltermann and Nielsen 2020). In brief, an overnight culture of bacterial cells was diluted 1:100 in fresh MHB and grown to OD600 0.5. After diluting the culture to ∼105 cfu/mL in MHB (1:2000–1:2500), 190 µL were dispensed into a 96-well plate (Thermo Fisher Scientific). Subsequently, 10 µL of a 20× PNA working solution was added to the respective well to adjust final concentrations from 10–0.3 µM. As a growth control, 10 µL of sterile nuclease-free water were added to the bacterial suspension. Growth was monitored over 24 h by measuring the optical density (OD) at 600 nm every 20 min in a Synergy H1 plate reader (BioTek) with continuous double-orbital shaking (237 cpm) at 37°C. The MIC of a PNA was determined as the lowest concentration that inhibited visible growth in the wells (OD [600 nm] <0.1).

PNA treatment of S. enterica SL1344 for isolation of total RNA

Overnight cultures of S. enterica SL1344 were diluted 1:100 in fresh MHB and grown to an OD600 of 0.5. Afterward, cultures were diluted to ∼106 cfu/mL in fresh MHB (1:100). Subsequently, 1.9 mL of the bacterial solution were transferred into 5 mL low-binding tubes (LABsolute) and 100 µL of a 20× PNA solution was added to reach a final concentration of 5 µM for each tested KFF-conjugated PNA. In parallel, an equal volume of sterile nuclease-free water, which was used as solvent for the test compounds, was added to the bacterial suspension and served as negative control. After a 15-min incubation at 37°C, RNAprotect Bacteria (Qiagen) was added to the samples according to the manufacturer's instructions. After 10 min, cells were pelleted at 21,100g and 4°C for 20 min. Pellets were either directly subjected to RNA isolation or stored at −20°C (<1 d) for subsequent processing.

Total RNA was isolated from bacterial cell pellets using the miRNeasy Mini kit (Qiagen) according to protocol #3 previously described in Popella et al. (2021). In brief, pellets were resuspended in TE buffer (pH 8.0) supplemented with 0.5 mg/mL lysozyme (Roth) and incubated for 5 min with repeated vortexing in between. After adding β-mercaptoethanol-containing RLT buffer and ethanol according to the manufacturer's instructions, samples were loaded on the columns. Wash steps were performed according to the manual. RNA concentration was measured using a NanoDrop spectrophotometer.

RNA-sequencing (RNA-seq)

RNA samples were delivered to Core Unit SysMed (Julius-Maximilian-University Würzburg) for RNA-seq. Briefly, after treating RNA samples with DNase, sufficient RNA quality was verified on a bioanalyzer (RNA chip, Agilent). Ribosomal RNA was depleted (RiboCop-META kit, Lexogen), and RNA was then reverse transcribed for cDNA library preparation using the CORALL kit (Lexogen) according to the manufacturer's instructions. After pooling cDNA library samples at equimolar amounts, quality was verified using a bioanalyzer (DNA chip, Agilent). The cDNA pools were sequenced using the NextSeq 500 system (HighOutput flow cell, 400 M, 1× 75 cycle single-end; Illumina).

RNA-seq read quantification

Read mapping and differential expression analysis were performed as previously described (Popella et al. 2021). Briefly, reads obtained from RNA sequencing were trimmed, filtered, and mapped against the respective reference genome. The reference genome consisted of the Salmonella enterica subsp. enterica serovar Typhimurium SL1344 (FQ312003.1) reference genome and three plasmids: pSLT_SL1344 (HE654724.1), pCol1B9_SL1344 (HE654725.1), and pRSF1010_SL1344 (HE654726.1) (Kröger et al. 2012). Bases with a Phred quality score of <10 were trimmed and adapters were removed using BBDuk. Next, the trimmed reads were mapped against the reference genome using BBMap (v38.84) and then assigned to genomic features, including both CDSs and annotated sRNAs (Kröger et al. 2012; Hör et al. 2020) using the featureCounts method of the Subread (2.0.1) package (Liao et al. 2014). Read mapping and quantification for the UPEC data was performed similarly, as described in Popella et al. (2022).

Differential expression analysis

Downstream analysis was performed using R (v4.1.2) and various packages from the Bioconductor project. Raw read counts were imported and analyzed with edgeR (v3.34.1) (Robinson et al. 2010). Genes with a cutoff value less than 10/L in at least three libraries were filtered, where L is the minimum library size in millions of counts, as proposed in Chen et al. (2016). Raw read counts were normalized with the trimmed mean of M values (TMM) normalization (Robinson and Oshlack 2010). Filtered libraries were then examined for batch effects as proposed in Peixoto et al. (2015). A consistent batch effect was identified between the two batches, which was corrected for by including a batch variable in the design matrix (Supplemental Fig. S7). Differential expression analysis was conducted using edgeR (Robinson et al. 2010). Estimation of quasi-likelihood (QL) dispersions was performed with the glmQLFit function. Then contrasts between all samples versus the water controls were created as input for the glmQLTest function. Genes with an absolute fold change >2 and an adjusted P-value (Benjamini–Hochberg, Benjamini and Hochberg 1995) <0.001 were considered differentially expressed. The differentially expressed genes were visualized by volcano plots and heatmaps created using ggplot2 (v3.3.0) and the ComplexHeatmap (v2.4.2) package, respectively. The differential expression analysis for the UPEC data was performed in a similar way (Popella et al. 2022).

Mismatch analysis

For the results shown in Figure 4, a modified analysis of off-target genes was performed. Each PNA sequence was screened for off-target matches using the MASON command line tool, while accepting all off-targets with 0–3 mismatches. Then, all significantly down-regulated genes were framed if they had an off-target site in the TIR of the respective gene, or in a TIR of a gene lying immediately upstream (<35 base gap) of the gene. The frame thickness indicates that 0, 1, 2, or 3 mismatches were present in the off-target site.

KEGG pathway enrichment analysis

To identify KEGG pathways for each gene, the R package KEGGREST (v1.28.0) was used. Additionally, gene sets of regulons curated in Westermann et al. (2016) were added prior to the analysis. Rotation gene set testing (fry version of the roast gene set enrichment test, Wu et al. 2010) was performed to identify enrichment of gene sets. Gene sets containing >10 genes with FDR-corrected P-values <0.001 are shown in Supplemental Figure S9, together with the median log2FC of genes in the respective pathway. If a sample had >10 significantly enriched gene sets, only the 10 gene sets with the lowest FDR adjusted P-values are shown.

Off-target analysis of melting temperature, RNA abundance, and RNA secondary structure

For Supplemental Figure S11, log2 fold changes and FDR-corrected P-values of transcripts with off-targets with at least seven consecutive matching bases were considered. Log2 fold changes and average log counts per million were calculated by edgeR, as described above. The Tm for off-target matches was calculated with the MELTING package as described before for the longest matching stretch in the off-target binding site (Dumousseau et al. 2012). To investigate the secondary structure of mRNAs surrounding the translation start site (−30 to +15 nt relative to the CDS start), the minimum free energy (MFE) was calculated using the RNAfold command of the ViennaRNA software suite (Lorenz et al. 2011).

DATA DEPOSITION

The codes of both the web- and command line version MASON are published under the MIT License (v1.0) on Github at https://github.com/BarquistLab/mason and https://github.com/BarquistLab/mason_commandline, respectively. The RNA-seq data sets from this study are available in GEO with accession numbers GSE199542 and GSE191313. The up- and downstream analysis of RNA-seq data is available on Github at https://github.com/BarquistLab/mason_paper.

SUPPLEMENTAL MATERIAL

Supplemental material is available for this article.

Supplementary Material

Supplemental Material
supp_29_5_570__DC1.html (1.2KB, html)

ACKNOWLEDGMENTS

We thank Barbara Plaschke for technical assistance and Tobias Kerrinnes for laboratory organization. We thank Kristina Popova for contributions in the early phase of the project. We especially thank Anke Sparmann for useful comments and edits on the manuscript. We further thank Michael Kütt for helping with adding the web server to the Internet and providing useful comments on web development. We also thank the Core Unit Systems Medicine (Julius-Maximilians-University, Würzburg) for handling the RNA samples for sequencing. This work was supported by the Bavarian Bayresq.net project Rbiotics (J.V., L.B.). Funding for the open access charge was provided by Bayresq.net.

Footnotes

Freely available online through the RNA Open Access option.

MEET THE FIRST AUTHOR

Jakob Jung.

Jakob Jung

Meet the First Author(s) is an editorial feature within RNA, in which the first author(s) of research-based papers in each issue have the opportunity to introduce themselves and their work to readers of RNA and the RNA research community. Jakob Jung is the first author of this paper, “Design and off-target prediction for antisense oligomers targeting bacterial mRNAs with the MASON web server.” Jakob is a PhD candidate in the groups of Jörg Vogel and Lars Barquist at the Institute of Molecular Infection Biology (IMIB) and the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg, Germany. The labs investigate the RNA of microbes during infection using experimental and computational approaches, and have recently been working on RNA-based therapeutic approaches.

What are the major results described in your paper and how do they impact this branch of the field?

We developed MASON, an easy-to-use web server for the design of bacterial antisense oligomers (ASOs) and the prediction of off-target effects. Importantly, MASON includes an off-target prediction algorithm based on our experimental growth experiments and RNA-seq data. We believe that the results of the experiments are important for the bacterial ASO community, as they reveal a dependency of off-target effects on mismatch position for antisense peptide nucleic acids (PNAs).

What led you to study RNA or this aspect of RNA science?

As a computational biologist, I am particularly interested in the development of antibiotics. Therefore, I was happy to be involved in this project within the Bavarian research network Bayresq.net in which multiple Bavarian research groups joined forces to develop new strategies against multiresistant pathogens using data science approaches. In our project, we focused on RNA-targeting antisense antibiotics and I developed computational methods to decipher their on- and off-target effects in bacteria.

During the course of these experiments, were there any surprising results or particular difficulties that altered your thinking and subsequent focus?

I was especially surprised when I saw that the antisense PNAs that contain two mismatches were still able to inhibit the growth of Salmonella. We had not expected this and therefore we decided to focus on off-target effects.

What are some of the landmark moments that provoked your interest in science or your development as a scientist?

It was around 2015 when I did my bachelor's degree in food technology and I first heard about CRISPR because of the work of Jennifer Doudna and Emmanuelle Charpentier. That totally got me excited about molecular biology and I decided to change the field of my studies and pursue a master's degree in cellular biotechnology.

If you were able to give one piece of advice to your younger self, what would that be?

Do not be afraid of change. And always document your code.

Are there specific individuals or groups who have influenced your philosophy or approach to science?

Many people have; especially my current supervisors Lars Barquist and Jörg Vogel, who have helped me become a better scientist. Also, my previous supervisors, Maria Suarez Diez and Margarita Martinez Medina from my MSc Thesis and internship, respectively, were great mentors and encouraged me to stay in research and pursue a PhD.

What are your subsequent near- or long-term career plans?

I am very excited about the field of antibiotics and antimicrobial resistance. Therefore, I want to be involved in antibiotic development, be it in academia or industry.

REFERENCES

  1. Aunins TR, Erickson KE, Chatterjee A. 2020. Transcriptome-based design of antisense inhibitors potentiates carbapenem efficacy in CRE Escherichia coli. Proc Natl Acad Sci 117: 30699–30709. 10.1073/pnas.1922187117 [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Baquero F, Levin BR. 2021. Proximate and ultimate causes of the bactericidal action of antibiotics. Nat Rev Microbiol 19: 123–132. 10.1038/s41579-020-00443-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Barkowsky G, Lemster A-L, Pappesch R, Jacob A, Krüger S, Schröder A, Kreikemeyer B, Patenge N. 2019. Influence of different cell-penetrating peptides on the antimicrobial efficiency of PNAs in Streptococcus pyogenes. Mol Ther Nucleic Acids 18: 444–454. 10.1016/j.omtn.2019.09.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc 57: 289–300. 10.1111/j.2517-6161.1995.tb02031.x [DOI] [Google Scholar]
  5. Chalk AM, Sonnhammer ELL. 2002. Computational antisense oligo prediction with a neural network model. Bioinformatics 18: 1567–1575. 10.1093/bioinformatics/18.12.1567 [DOI] [PubMed] [Google Scholar]
  6. Chen Y, Lun ATL, Smyth GK. 2016. From reads to genes to pathways: differential expression analysis of RNA-Seq experiments using Rsubread and the edgeR quasi-likelihood pipeline. F1000Res 5: 1438. 10.12688/f1000research.8987.2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cock PJA, Antao T, Chang JT, Chapman BA, Cox CJ, Dalke A, Friedberg I, Hamelryck T, Kauff F, Wilczynski B, et al. 2009. Biopython: freely available Python tools for computational molecular biology and bioinformatics. Bioinformatics 25: 1422–1423. 10.1093/bioinformatics/btp163 [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Courtney CM, Chatterjee A. 2015. Sequence-specific peptide nucleic acid-based antisense inhibitors of TEM-1 β-lactamase and mechanism of adaptive resistance. ACS Infect Dis 1: 253–263. 10.1021/acsinfecdis.5b00042 [DOI] [PubMed] [Google Scholar]
  9. Deere J, Iversen P, Geller BL. 2005. Antisense phosphorodiamidate morpholino oligomer length and target position effects on gene-specific inhibition in Escherichia coli. Antimicrob Agents Chemother 49: 249–255. 10.1128/AAC.49.1.249-255.2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Dryselius R, Aswasti SK, Rajarao GK, Nielsen PE, Good L. 2003. The translation start codon region is sensitive to antisense PNA inhibition in Escherichia coli. Oligonucleotides 13: 427–433. 10.1089/154545703322860753 [DOI] [PubMed] [Google Scholar]
  11. Dumousseau M, Rodriguez N, Juty N, Le Novère N. 2012. MELTING, a flexible platform to predict the melting temperatures of nucleic acids. BMC Bioinformatics 13: 101. 10.1186/1471-2105-13-101 [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Egholm M, Buchardt O, Christensen L, Behrens C, Freier SM, Driver DA, Berg RH, Kim SK, Norden B, Nielsen PE. 1993. PNA hybridizes to complementary oligonucleotides obeying the Watson-Crick hydrogen-bonding rules. Nature 365: 566–568. 10.1038/365566a0 [DOI] [PubMed] [Google Scholar]
  13. Eller KA, Aunins TR, Courtney CM, Campos JK, Otoupal PB, Erickson KE, Madinger NE, Chatterjee A. 2021. Facile accelerated specific therapeutic (FAST) platform develops antisense therapies to counter multidrug-resistant bacteria. Commun Biol 4: 331. 10.1038/s42003-021-01856-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Eriksson M, Nielsen PE, Good L. 2002. Cell permeabilization and uptake of antisense peptide-peptide nucleic acid (PNA) into Escherichia coli. J Biol Chem 277: 7144–7147. 10.1074/jbc.M106624200 [DOI] [PubMed] [Google Scholar]
  15. Geller BL, Deere JD, Stein DA, Kroeker AD, Moulton HM, Iversen PL. 2003. Inhibition of gene expression in Escherichia coli by antisense phosphorodiamidate morpholino oligomers. Antimicrob Agents Chemother 47: 3233–3239. 10.1128/AAC.47.10.3233-3239.2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Giesen U, Kleider W, Berding C, Geiger A, Orum H, Nielsen PE. 1998. A formula for thermal stability (Tm) prediction of PNA/DNA duplexes. Nucleic Acids Res 26: 5004–5006. 10.1093/nar/26.21.5004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Goltermann L, Nielsen PE. 2020. PNA antisense targeting in bacteria: determination of antibacterial activity (MIC) of PNA-peptide conjugates. Peptide Nucleic Acids 231–239. 10.1007/978-1-0716-0243-0_14 [DOI] [PubMed] [Google Scholar]
  18. Goltermann L, Yavari N, Zhang M, Ghosal A, Nielsen PE. 2019. PNA length restriction of antibacterial activity of peptide-PNA conjugates in Escherichia coli through effects of the inner membrane. Front Microbiol 10: 1032. 10.3389/fmicb.2019.01032 [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Good L. 2002. Antisense inhibition of bacterial gene expression and cell growth. Methods Mol Biol 208: 237–248. 10.1385/1-59259-290-2:237 [DOI] [PubMed] [Google Scholar]
  20. Good L, Nielsen PE. 1998. Inhibition of translation and bacterial growth by peptide nucleic acid targeted to ribosomal RNA. Proc Natl Acad Sci 95: 2073–2076. 10.1073/pnas.95.5.2073 [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Good L, Awasthi SK, Dryselius R, Larsson O, Nielsen PE. 2001. Bactericidal antisense effects of peptide–PNA conjugates. Nat Biotechnol 19: 360–364. 10.1038/86753 [DOI] [PubMed] [Google Scholar]
  22. Grinberg M. 2018. Flask web development: developing web applications with Python. O'Reilly Media, Inc., Sebastopol, CA. [Google Scholar]
  23. Hatamoto M, Nakai K, Ohashi A, Imachi H. 2009. Sequence-specific bacterial growth inhibition by peptide nucleic acid targeted to the mRNA binding site of 16S rRNA. Appl Microbiol Biotechnol 84: 1161–1168. 10.1007/s00253-009-2099-0 [DOI] [PubMed] [Google Scholar]
  24. Hegarty JP, Stewart DB Sr. 2018. Advances in therapeutic bacterial antisense biotechnology. Appl Microbiol Biotechnol 102: 1055–1065. 10.1007/s00253-017-8671-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Hoiseth SK, Stocker BA. 1981. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 291: 238–239. 10.1038/291238a0 [DOI] [PubMed] [Google Scholar]
  26. Hör J, Matera G, Vogel J, Gottesman S, Storz G. 2020. Trans-acting small RNAs and their effects on gene expression in Escherichia coli and Salmonella enterica. EcoSal Plus 9: 10.1128/ecosalplus.ESP-0030-2019. 10.1128/ecosalplus.ESP-0030-2019 [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Hör J, Jung J, Ðurica-Mitić S, Barquist L, Vogel J. 2022. INRI-seq enables global cell-free analysis of translation initiation and off-target effects of antisense inhibitors. Nucleic Acids Res 50: e128. 10.1093/nar/gkac838 [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Huber W, Carey VJ, Gentleman R, Anders S, Carlson M, Carvalho BS, Bravo HC, Davis S, Gatto L, Girke T, et al. 2015. Orchestrating high-throughput genomic analysis with Bioconductor. Nat Methods 12: 115–121. 10.1038/nmeth.3252 [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Human Microbiome Project Consortium. 2012. A framework for human microbiome research. Nature 486: 215–221. 10.1038/nature11209 [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Iversen PL. 2001. Phosphorodiamidate morpholino oligomers: favorable properties for sequence-specific gene inactivation. Curr Opin Mol Ther 3: 235–238. [PubMed] [Google Scholar]
  31. Jensen KK, Orum H, Nielsen PE, Nordén B. 1997. Kinetics for hybridization of peptide nucleic acids (PNA) with DNA and RNA studied with the BIAcore technique. Biochemistry 36: 5072–5077. 10.1021/bi9627525 [DOI] [PubMed] [Google Scholar]
  32. Jiang H, Wong WH. 2008. SeqMap: mapping massive amount of oligonucleotides to the genome. Bioinformatics 24: 2395–2396. 10.1093/bioinformatics/btn429 [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Kröger C, Dillon SC, Cameron ADS, Papenfort K, Sivasankaran SK, Hokamp K, Chao Y, Sittka A, Hébrard M, Händler K, et al. 2012. The transcriptional landscape and small RNAs of Salmonella enterica serovar Typhimurium. Proc Natl Acad Sci 109: E1277–E1286. 10.1073/pnas.1201061109 [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Lee HT, Kim SK, Lee JB, Yoon JW. 2019. A novel peptide nucleic acid against the cytidine monophosphate kinase of S. aureus inhibits staphylococcal infection in vivo. Mol Ther Nucleic Acids 18: 245–252. 10.1016/j.omtn.2019.08.021 [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Li B, Chen PB, Diao Y. 2021. CRISPR-SE: a brute force search engine for CRISPR design. NAR Genom Bioinform 3: lqab013. 10.1093/nargab/lqab013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Liao Y, Smyth GK, Shi W. 2014. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30: 923–930. 10.1093/bioinformatics/btt656 [DOI] [PubMed] [Google Scholar]
  37. Liu G, Zhang Y, Zhang T. 2020. Computational approaches for effective CRISPR guide RNA design and evaluation. Comput Struct Biotechnol J 18: 35–44. 10.1016/j.csbj.2019.11.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Lorenz R, Bernhart SH, Höner Zu Siederdissen C, Tafer H, Flamm C, Stadler PF, Hofacker IL. 2011. ViennaRNA Package 2.0. Algorithms Mol Biol 6: 26. 10.1186/1748-7188-6-26 [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Moustafa DA, Wu AW, Zamora D, Daly SM, Sturge CR, Pybus C, Geller BL, Goldberg JB, Greenberg DE. 2021. Peptide-conjugated phosphorodiamidate morpholino oligomers retain activity against multidrug-resistant Pseudomonas aeruginosa in vitro and in vivo. MBio 12: e02411-20. 10.1128/mBio.02411-20 [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Murray CJL, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G, Gray A, Han C, Bisignano C, Rao P, Wool E, et al. 2022. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 399: 629–655. 10.1016/S0140-6736(21)02724-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Nielsen E. 2006. RNA targeting using peptide nucleic acid. In RNA towards medicine (ed. Erdmann V, Barciszewski J, Brosius J), pp. 395–403. Springer, Berlin, Heidelberg. [DOI] [PubMed] [Google Scholar]
  42. Nielsen PE, Egholm M, Berg RH, Buchardt O. 1991. Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide. Science 254: 1497–1500. 10.1126/science.1962210 [DOI] [PubMed] [Google Scholar]
  43. Nielsen PE, Haaima G, Lohse A, Buchardt O. 1996. Peptide nucleic acids (PNAs) containing thymine monomers derived from chiral amino acids: hybridization and solubility properties of D-lysine PNA. Angew Chem Int Ed Engl 35: 1939–1942. 10.1002/anie.199619391 [DOI] [Google Scholar]
  44. Oh E, Zhang Q, Jeon B. 2014. Target optimization for peptide nucleic acid (PNA)-mediated antisense inhibition of the CmeABC multidrug efflux pump in Campylobacter jejuni. J Antimicrob Chemother 69: 375–380. 10.1093/jac/dkt381 [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Owczarzy R, Tataurov AV, Wu Y, Manthey JA, McQuisten KA, Almabrazi HG, Pedersen KF, Lin Y, Garretson J, McEntaggart NO, et al. 2008. IDT SciTools: a suite for analysis and design of nucleic acid oligomers. Nucleic Acids Res 36: W163–W169. 10.1093/nar/gkn198 [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Peixoto L, Risso D, Poplawski SG, Wimmer ME, Speed TP, Wood MA, Abel T. 2015. How data analysis affects power, reproducibility and biological insight of RNA-seq studies in complex datasets. Nucleic Acids Res 43: 7664–7674. 10.1093/nar/gkv736 [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Pifer R, Greenberg DE. 2020. Antisense antibacterial compounds. Transl Res 223: 89–106. 10.1016/j.trsl.2020.06.001 [DOI] [PubMed] [Google Scholar]
  48. Popella L, Jung J, Popova K, Ðurica-Mitić S, Barquist L, Vogel J. 2021. Global RNA profiles show target selectivity and physiological effects of peptide-delivered antisense antibiotics. Nucleic Acids Res 49: 4705–4724. 10.1093/nar/gkab242 [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Popella L, Jung J, Do PT, Hayward RJ, Barquist L, Vogel J. 2022. Comprehensive analysis of PNA-based antisense antibiotics targeting various essential genes in uropathogenic Escherichia coli. Nucleic Acids Res 50: 6435–6452. 10.1093/nar/gkac362 [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Quinlan AR, Hall IM. 2010. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26: 841–842. 10.1093/bioinformatics/btq033 [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Ratilainen T, Holmén A, Tuite E, Nielsen PE, Nordén B. 2000. Thermodynamics of sequence-specific binding of PNA to DNA. Biochemistry 39: 7781–7791. 10.1021/bi000039g [DOI] [PubMed] [Google Scholar]
  52. Robinson MD, Oshlack A. 2010. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol 11: R25. 10.1186/gb-2010-11-3-r25 [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Robinson MD, McCarthy DJ, Smyth GK. 2010. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26: 139–140. 10.1093/bioinformatics/btp616 [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Sciabola S, Xi H, Cruz D, Cao Q, Lawrence C, Zhang T, Rotstein S, Hughes JD, Caffrey DR, Stanton RV. 2021. PFRED: a computational platform for siRNA and antisense oligonucleotides design. PLoS ONE 16: e0238753. 10.1371/journal.pone.0238753 [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Sully EK, Geller BL. 2016. Antisense antimicrobial therapeutics. Curr Opin Microbiol 33: 47–55. 10.1016/j.mib.2016.05.017 [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Tan X-X, Actor JK, Chen Y. 2005. Peptide nucleic acid antisense oligomer as a therapeutic strategy against bacterial infection: proof of principle using mouse intraperitoneal infection. Antimicrob Agents Chemother 49: 3203–3207. 10.1128/AAC.49.8.3203-3207.2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Tilley LD, Hine OS, Kellogg JA, Hassinger JN, Weller DD, Iversen PL, Geller BL. 2006. Gene-specific effects of antisense phosphorodiamidate morpholino oligomer-peptide conjugates on Escherichia coli and Salmonella enterica serovar typhimurium in pure culture and in tissue culture. Antimicrob Agents Chemother 50: 2789–2796. 10.1128/AAC.01286-05 [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Vangay P, Ward T, Gerber JS, Knights D. 2015. Antibiotics, pediatric dysbiosis, and disease. Cell Host Microbe 17: 553–564. 10.1016/j.chom.2015.04.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Vogel J. 2020. An RNA biology perspective on species-specific programmable RNA antibiotics. Mol Microbiol 113: 550–559. 10.1111/mmi.14476 [DOI] [PubMed] [Google Scholar]
  60. Westermann AJ, Förstner KU, Amman F, Barquist L, Chao Y, Schulte LN, Müller L, Reinhardt R, Stadler PF, Vogel J. 2016. Dual RNA-seq unveils noncoding RNA functions in host-pathogen interactions. Nature 529: 496–501. 10.1038/nature16547 [DOI] [PubMed] [Google Scholar]
  61. Wu D, Lim E, Vaillant F, Asselin-Labat M-L, Visvader JE, Smyth GK. 2010. ROAST: rotation gene set tests for complex microarray experiments. Bioinformatics 26: 2176–2182. 10.1093/bioinformatics/btq401 [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Xia T, SantaLucia J Jr, Burkard ME, Kierzek R, Schroeder SJ, Jiao X, Cox C, Turner DH. 1998. Thermodynamic parameters for an expanded nearest-neighbor model for formation of RNA duplexes with Watson-Crick base pairs. Biochemistry 37: 14719–14735. 10.1021/bi9809425 [DOI] [PubMed] [Google Scholar]
  63. Ziebuhr W, Vogel J. 2015. The end is not the end: remnants of tRNA precursors live on to sponge up small regulatory RNAs. Mol Cell 58: 389–390. 10.1016/j.molcel.2015.04.032 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental Material
supp_29_5_570__DC1.html (1.2KB, html)

Articles from RNA are provided here courtesy of The RNA Society

RESOURCES